152 related articles for article (PubMed ID: 8894618)
61. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
[TBL] [Abstract][Full Text] [Related]
62. Characterization of high affinity opioid binding sites in rat periaqueductal gray P2 membrane.
Fedynyshyn JP; Kwiat G; Lee NM
Eur J Pharmacol; 1989 Jan; 159(1):83-8. PubMed ID: 2540013
[TBL] [Abstract][Full Text] [Related]
63. Discriminative stimulus effects of a centrally administered, delta-opioid peptide (D-Pen2-D-Pen5-enkephalin) in pigeons.
Jewett DC; Mosberg HI; Woods JH
Psychopharmacology (Berl); 1996 Oct; 127(3):225-30. PubMed ID: 8912400
[TBL] [Abstract][Full Text] [Related]
64. Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes.
Onali P; Dedoni S; Olianas MC
J Pharmacol Exp Ther; 2010 Jan; 332(1):255-65. PubMed ID: 19828880
[TBL] [Abstract][Full Text] [Related]
65. Pharmacological properties of newly synthesized derivatives of (-)-6 beta-acetylthionormorphine and their interactions with opioid receptors.
Takayanagi I; Koike K; Suzuki T
Gen Pharmacol; 1990; 21(5):605-11. PubMed ID: 2177430
[TBL] [Abstract][Full Text] [Related]
66. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat.
Miaskowski C; Taiwo YO; Levine JD
Eur J Pharmacol; 1991 Dec; 205(3):247-52. PubMed ID: 1667910
[TBL] [Abstract][Full Text] [Related]
67. Delta-opioid-receptor activation by [D-Pen2,D-Pen5]enkephalin and morphine inhibits substance P release from trigeminal nucleus slices.
Suarez-Roca H; Maixner W
Eur J Pharmacol; 1992 Dec; 229(1):1-7. PubMed ID: 1282103
[TBL] [Abstract][Full Text] [Related]
68. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
Prather PL; Tsai AW; Law PY
J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
[TBL] [Abstract][Full Text] [Related]
69. Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates.
Newman LC; Sands SS; Wallace DR; Stevens CW
J Pharmacol Exp Ther; 2002 Apr; 301(1):364-70. PubMed ID: 11907194
[TBL] [Abstract][Full Text] [Related]
70. [3H][D-Pen2, D-Pen5]enkephalin binding to delta opioid receptors on intact neuroblastoma-glioma (NG 108-15) hybrid cells.
Knapp RJ; Yamamura HI
Life Sci; 1990; 46(20):1457-63. PubMed ID: 2161068
[TBL] [Abstract][Full Text] [Related]
71. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex.
Schoffelmeer AN; Yao YH; Gioannini TL; Hiller JM; Ofri D; Roques BP; Simon EJ
J Pharmacol Exp Ther; 1990 Apr; 253(1):419-26. PubMed ID: 2158552
[TBL] [Abstract][Full Text] [Related]
72. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
73. Modulation of cholinergic neurotransmission in guinea-pig airways by opioids.
Belvisi MG; Stretton CD; Barnes PJ
Br J Pharmacol; 1990 May; 100(1):131-7. PubMed ID: 1695531
[TBL] [Abstract][Full Text] [Related]
74. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
Rahmani NH; Gulati A; Bhargava HN
Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
[TBL] [Abstract][Full Text] [Related]
75. Expression of the mu-opioid receptor in CHO cells: ability of mu-opioid ligands to promote alpha-azidoanilido[32P]GTP labeling of multiple G protein alpha subunits.
Chakrabarti S; Prather PL; Yu L; Law PY; Loh HH
J Neurochem; 1995 Jun; 64(6):2534-43. PubMed ID: 7760033
[TBL] [Abstract][Full Text] [Related]
76. Evidence for delta receptor mediation of [D-Pen2,D-Pen5]-enkephalin (DPDPE) analgesia in mice.
Heyman JS; Mosberg HI; Porreca F
NIDA Res Monogr; 1986; 75():442-5. PubMed ID: 2828989
[TBL] [Abstract][Full Text] [Related]
77. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
[TBL] [Abstract][Full Text] [Related]
78. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
[TBL] [Abstract][Full Text] [Related]
79. The use of [3H]-[D-Pen2,D-Pen5]enkephalin as a highly selective ligand for the delta-binding site.
Cotton R; Kosterlitz HW; Paterson SJ; Rance MJ; Traynor JR
Br J Pharmacol; 1985 Apr; 84(4):927-32. PubMed ID: 2988685
[TBL] [Abstract][Full Text] [Related]
80. Interactions of N-cyclopropylmethyl(-)-6 beta-acetylthionormorphine with mu-, kappa-, delta- and sigma-opioid receptors.
Takayanagi I; Koike K; Satoh M
Gen Pharmacol; 1991; 22(5):965-7. PubMed ID: 1662176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
